Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial
Potential Side Effects and Precautions: A Balanced Perspective Generally considered safe when taken at the recommended dosages, ALCAR is well-tolerated by most individuals
In the STEP-1 trial (N=1,961), gastrointestinal adverse events were the most common side effect category, reported by 74.2% of semaglutide participants versus 47.9% on placebo [2]
Wegovy pill page) (FDA Rybelsus label, 2025
However, the solubility of the finished product obtained by the existing purification methods is not good, and other means are needed to improve the solubility of the finished product in the subsequent research and application process
doi: 10.1042/BST20150014 87 GerstgrasserAMelhemHLeonardiIAtrottKSchferMWernerSet al